List of Tables
Table 1. Global Heart Failure Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnosis
Table 3. Key Players of Prognosis
Table 4. Key Players of Treatment Options and Treatment Algorithm
Table 5. Global Heart Failure Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Heart Failure Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Heart Failure Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Heart Failure Therapeutics Market Share by Region (2019-2024)
Table 9. Global Heart Failure Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Heart Failure Therapeutics Market Share by Region (2025-2030)
Table 11. Heart Failure Therapeutics Market Trends
Table 12. Heart Failure Therapeutics Market Drivers
Table 13. Heart Failure Therapeutics Market Challenges
Table 14. Heart Failure Therapeutics Market Restraints
Table 15. Global Heart Failure Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Heart Failure Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Heart Failure Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Therapeutics as of 2023)
Table 18. Ranking of Global Top Heart Failure Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Heart Failure Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Heart Failure Therapeutics Product Solution and Service
Table 22. Date of Enter into Heart Failure Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Heart Failure Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Heart Failure Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Heart Failure Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Heart Failure Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Heart Failure Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Heart Failure Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Heart Failure Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Heart Failure Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Heart Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Heart Failure Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Heart Failure Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Heart Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Heart Failure Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Heart Failure Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Heart Failure Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Heart Failure Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Heart Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Heart Failure Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Heart Failure Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Heart Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Heart Failure Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Heart Failure Therapeutics Product
Table 50. Bayer Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Cynokinetics Company Detail
Table 53. Cynokinetics Business Overview
Table 54. Cynokinetics Heart Failure Therapeutics Product
Table 55. Cynokinetics Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Cynokinetics Recent Development
Table 57. Les Laboratoires Servier Company Detail
Table 58. Les Laboratoires Servier Business Overview
Table 59. Les Laboratoires Servier Heart Failure Therapeutics Product
Table 60. Les Laboratoires Servier Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Les Laboratoires Servier Recent Development
Table 62. Merck & Co. Company Detail
Table 63. Merck & Co. Business Overview
Table 64. Merck & Co. Heart Failure Therapeutics Product
Table 65. Merck & Co. Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Merck & Co. Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Heart Failure Therapeutics Product
Table 70. Novartis Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Procoralan Company Detail
Table 73. Procoralan Business Overview
Table 74. Procoralan Heart Failure Therapeutics Product
Table 75. Procoralan Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Procoralan Recent Development
Table 77. Bristol-Myers Squibb Company Company Detail
Table 78. Bristol-Myers Squibb Company Business Overview
Table 79. Bristol-Myers Squibb Company Heart Failure Therapeutics Product
Table 80. Bristol-Myers Squibb Company Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Cardiorentis AG Company Detail
Table 83. Cardiorentis AG Business Overview
Table 84. Cardiorentis AG Heart Failure Therapeutics Product
Table 85. Cardiorentis AG Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Cardiorentis AG Recent Development
Table 87. CVie Therapeutics Limited Company Detail
Table 88. CVie Therapeutics Limited Business Overview
Table 89. CVie Therapeutics Limited Heart Failure Therapeutics Product
Table 90. CVie Therapeutics Limited Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 91. CVie Therapeutics Limited Recent Development
Table 92. Orion Corporation Company Detail
Table 93. Orion Corporation Business Overview
Table 94. Orion Corporation Heart Failure Therapeutics Product
Table 95. Orion Corporation Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Orion Corporation Recent Development
Table 97. PhaseBio Pharmaceuticals Company Detail
Table 98. PhaseBio Pharmaceuticals Business Overview
Table 99. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product
Table 100. PhaseBio Pharmaceuticals Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 101. PhaseBio Pharmaceuticals Recent Development
Table 102. Market Segment by Product Type Company Detail
Table 103. Market Segment by Product Type Business Overview
Table 104. Market Segment by Product Type Heart Failure Therapeutics Product
Table 105. Market Segment by Product Type Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 106. Market Segment by Product Type Recent Development
Table 107. B-Blockers Company Detail
Table 108. B-Blockers Business Overview
Table 109. B-Blockers Heart Failure Therapeutics Product
Table 110. B-Blockers Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 111. B-Blockers Recent Development
Table 112. Calcium Channel Blockers Company Detail
Table 113. Calcium Channel Blockers Business Overview
Table 114. Calcium Channel Blockers Heart Failure Therapeutics Product
Table 115. Calcium Channel Blockers Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 116. Calcium Channel Blockers Recent Development
Table 117. Cardiac Glycosides Company Detail
Table 118. Cardiac Glycosides Business Overview
Table 119. Cardiac Glycosides Heart Failure Therapeutics Product
Table 120. Cardiac Glycosides Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 121. Cardiac Glycosides Recent Development
Table 122. Diuretics Company Detail
Table 123. Diuretics Business Overview
Table 124. Diuretics Heart Failure Therapeutics Product
Table 125. Diuretics Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 126. Diuretics Recent Development
Table 127. Morphine Company Detail
Table 128. Morphine Business Overview
Table 129. Morphine Heart Failure Therapeutics Product
Table 130. Morphine Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 131. Morphine Recent Development
Table 132. Vasodilators/Nitrates Company Detail
Table 133. Vasodilators/Nitrates Business Overview
Table 134. Vasodilators/Nitrates Heart Failure Therapeutics Product
Table 135. Vasodilators/Nitrates Revenue in Heart Failure Therapeutics Business (2019-2024) & (US$ Million)
Table 136. Vasodilators/Nitrates Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Heart Failure Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Heart Failure Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Diagnosis Features
Figure 4. Prognosis Features
Figure 5. Treatment Options and Treatment Algorithm Features
Figure 6. Global Heart Failure Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Heart Failure Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Medical Research Organization Case Studies
Figure 11. Heart Failure Therapeutics Report Years Considered
Figure 12. Global Heart Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Heart Failure Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Heart Failure Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Heart Failure Therapeutics Market Share by Players in 2023
Figure 16. Global Top Heart Failure Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Heart Failure Therapeutics Revenue in 2023
Figure 18. North America Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Heart Failure Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Heart Failure Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Heart Failure Therapeutics Market Share by Region (2019-2030)
Figure 32. China Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Heart Failure Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Heart Failure Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Heart Failure Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 47. Cynokinetics Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 48. Les Laboratoires Servier Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 49. Merck & Co. Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 51. Procoralan Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 52. Bristol-Myers Squibb Company Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 53. Cardiorentis AG Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 54. CVie Therapeutics Limited Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 55. Orion Corporation Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 56. PhaseBio Pharmaceuticals Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 57. Market Segment by Product Type Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 58. B-Blockers Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 59. Calcium Channel Blockers Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 60. Cardiac Glycosides Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 61. Diuretics Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 62. Morphine Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 63. Vasodilators/Nitrates Revenue Growth Rate in Heart Failure Therapeutics Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed